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CLINICAL INVESTIGATION
Multimorbidity and Mental Health-Related Quality of Life
and Risk of Completed Suicide
Melissa Y. Wei, MD, MPH, MS* and Kenneth J. Mukamal, MD, MPH, MA†
BACKGROUND: Physical functioning indexed multimor-
bidity is strongly associated with long-term mortality, but
its role in poor mental health has not been quantified.
METHODS: A total of 252 002 community-dwelling adults
in the Nurses’ Health Study (NHS), NHS II, and Health Profes-
sionals Follow-up Study (HPFS) prospective cohorts reported
physician-diagnosed diseases and the Short Form-36 over
8 years and had 24-year follow-up for suicide mortality. We
quantified multimorbidity using a multimorbidity-weighted
index (MWI). We used multivariable-adjusted proportional
hazards models with competing risks for suicide mortality and
mixed-effects models to estimate mental health-related quality
of life (HRQOL).
RESULTS: Multimorbidity was associated with an increased
risk of suicide mortality in an approximately linear manner,
with roughly two- to threefold higher risk in adults with the
highest vs lowest quartile MWI in adjusted models: NHS
hazard ratio (HR) = 3.01 (95% confidence interval
[CI] = 1.48-6.11); NHS II HR = 3.04 (95% CI = 1.82-5.09);
HPFS HR = 1.74 (95% CI = 1.08-2.81). Greater MWI was
associated with worse mental HRQOL 8 years later across
all scales and the mental component summary (MCS) in a
dose-response manner. This association was attenuated but
persisted after adjustment for baseline mental HRQOL and
other covariates. Adults with the highest quartile MWI had
lower MCS in adjusted models compared with those with
the lowest quartile MWI: NHS ß = −0.61 (95% CI = −0.78
to −0.44); NHS II ß = −1.25 (95% CI = −1.44 to −1.06).
CONCLUSION: Multimorbidity is associated with sub-
stantially higher suicide mortality risk and worse mental
HRQOL across all available scales, even when indexed to
physical functioning. These results highlight the substantial
mental health burden imposed by multimorbidity at all ages
and sexes. J Am Geriatr Soc 67:511–519, 2019.
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Suicide consistently ranks among the top 10 causes ofdeath for US adults.1 Between 1999 and 2016, suicide
rates increased 28% for men and women ages 10 to
74 years.2 Within 4 weeks of death, half used a healthcare
service (outpatient, inpatient, emergency department visits),
and in the year prior, 83% made a healthcare visit.3 Despite
this, providers lack effective tools for screening and inter-
vening beyond traditional risk factors such as mental
health4 and substance use conditions5 or suicidal ideation.
Older adults have a high burden of physical illness that
adversely impacts mental health and vice versa.6 Physical
conditions that are incurable and/or severe, such as acquired
immunodeficiency syndrome, are independent risk factors
for suicidal ideation7,8 and mortality.9 Although prior stud-
ies established mental and physical conditions as risk factors
for suicide in older adults, quantifying this relationship has
generally taken a disease-specific approach and relied on
case-control designs.9–11 However, diseases are dynamic and
rarely remain in isolation over the life span.12 Multimorbid-
ity, the coexistence of multiple chronic conditions and most
common experience among patients, has increased over time
and is particularly prevalent in older adults, ranging from
26% in noninstitutionalized adults to 71% in hospitalized
adults between 2009 and 2012.13 Suicide risk due to multi-
morbidity remains poorly understood.
Multimorbidity may be a useful construct to quantify
cumulative burden of chronic mental and physical illness and
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help clinicians screen for suicide risk, but comprehensive tools
to measure it have been limited. We developed and validated a
patient-centered measure of multimorbidity, the multimorbidity-
weighted index (MWI),14,15 that weights diseases to patient-
reported physical functioning. MWI is strongly associated with
physical and cognitive function and mortality and captures a
broader range of multimorbidity than other indices.14,15 Impor-
tantly, the Short Form (SF)-36 physical functioning scale to
which MWI is weighted is completely uncorrelated with SF-
36’s mental health-related quality of life (HRQOL) scales, by
design.16 Thus MWI represents a unique instrument with which
to gauge the full burden of multimorbidity on mental health,
for its weighting would minimize the role of multimorbidity on
mental HRQOL, and it accurately quantifies both low and high
degrees of multimorbidity.
To assess prospective associations of multimorbidity, as
estimated by MWI, with mental HRQOL and risk of suicide
mortality, we studied three large cohorts of young through
older community-dwelling adults with over 24-year follow-
up and, in two cohorts, repeated assessments of mental
HRQOL. We sought to quantify the longitudinal burden




We included three nationally-sampled prospective cohorts
of US community-dwelling participants, the Nurses’
Health Study (NHS), NHS II, and Health Professionals
Follow-up Study (HPFS). NHS was established in 1976
when 121 701 female nurses aged 30 to 55 years com-
pleted a mailed questionnaire on diet, lifestyle, and medi-
cal history. A younger cohort of female nurses, NHS II,
was established in 1989 and enrolled 116 686 nurses aged
25 to 42 years who responded to a similar questionnaire.
HPFS enrolled 51 530 male health professionals aged
40 to 75 years in 1986 who also submitted biennial ques-
tionnaires. Participants reported physician-diagnosed chronic
conditions in 1992-1993 and had follow-up on HRQOL
through 2000-2001 and suicide mortality through 2016. We
excluded pregnant women because pregnancy is associated
with reduced HRQOL.17 This study was approved by a
blinded institutional review board.
Multimorbidity Measurement
Multimorbidity was assessed using the validated MWI.14,15
Briefly, chronic conditions were weighted by their esti-
mated impact on physical functioning and then summed to
form each individual’s MWI. MWI represents an individ-
ual’s cumulative burden of chronic conditions. Further,
each 1-point increase in MWI conveniently calibrates to a
1-point decrease in SF-36 physical functioning. For this
analysis, we applied our previously established weights to
65 available conditions reported in 1992-1993 to create a
baseline MWI for each participant.
Depression and substance abuse disorders were not
assessed as self-reported conditions at baseline so were not
included in the MWI in this study. For robustness, we
included these conditions as defined by regular antidepressant
and tranquilizer use, available in NHS II and HPFS. We
assigned the MWI weighting for depression to antidepressant
use, and used the weighting for alcohol abuse to impute a
weighting for tranquilizer use. Alcohol abuse was assessed in
NHS II only.
Suicide Mortality Assessment
Deaths through December 31, 2016, were identified at the
end of each 2-year cycle through the National Death
Index.18,19 Suicide was defined using International Classifi-
cation of Diseases, Revision 8, codes for suicide and self-
inflicted injury (E950-E959). Cases included suicide and
self-inflicted poisoning by solid or liquid substances, gases
in domestic use, or other gases; suicide and self-inflicted
injury by hanging, strangulation and suffocation, submer-
sion, firearms and explosives, cutting and piercing instru-
ments, jumping from high place, other and unspecified
means; and late effects of self-inflicted injury.
HRQOL Assessment
SF-36 is among the most widely used health survey instru-
ments to assess HRQOL and was extensively validated.20 It
includes eight scales and two summary component scores
self-reported in 1992 and 2000 (NHS) and 1993 and 2001
(NHS II). In HPFS, only physical functioning was assessed,
and its association with MWI was reported previously.21
SF-36 comprises eight overlapping scales: physical
functioning, role limitations due to physical health prob-
lems (role-physical), bodily pain, general health, vitality,
social functioning, role limitations to emotional health
problems (role-emotional), and mental health. The mental
component summary (MCS) and physical component sum-
mary (PCS) are computed based on the eight scales and are
orthogonal (uncorrelated) by design,16 precluding risk fac-
tors that influence physical HRQOL from affecting mental
HRQOL. MCS includes social functioning, role-emotional,
mental health, general health, and vitality. PCS includes physi-
cal functioning, role-physical, bodily pain, general health, and
vitality. General health and vitality are in both MCS and PCS.
We used MCS as our primary mental HRQOL outcome and
examined individual mental health subscales for robustness.
We also present results for physical HRQOL as a comparator;
we previously reported strong effects of MWI on physical
HRQOL, as expected from its weighting.
Each of the scales and summary component scores
range from 0 to 100, with higher scores indicating better
HRQOL. Scores are calibrated so the mean for the general
US population on each scale, and summary is 50 with a
standard deviation of 10.16
Covariate Assessment
We selected covariates considered potentially important predic-
tors for multimorbidity and HRQOL.22–27 These included age,
race, body mass index, smoking status, geographic region,
alcohol intake, coffee intake, marital status, and living alone.
Additionally, in NHS, religious service attendance was avail-
able and adjusted for due to its strong inverse association
with suicide mortality.27 Participant characteristics were
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assessed at baseline in 1992 except alcohol and coffee intake,
assessed in 1990.
Statistical Analysis
We conducted analyses for two sets of outcomes, suicide
mortality and mental HRQOL. For the first set of ana-
lyses, suicide mortality, we used multivariable Cox pro-
portional hazards regression models with censoring for
nonsuicide mortality and nondeaths28 to determine the
association of MWI with suicide mortality. We calculated
hazard ratios (HRs) and 95% confidence intervals (CIs)
comparing each 1-point increase in MWI and quartiles of
MWI through Cox proportional hazards modeling and the
Efron29 method for handling ties. We assessed cohorts sep-
arately; then, given similar trends, we pooled results using
fixed-effects meta-analysis to obtain the DerSimonian-
Laird estimator.30
To assess for a potential nonlinear association between
MWI and suicide mortality, we used restricted cubic
splines31 and winsorized the top 5% MWI values to reduce
the possible effect of spurious outliers.32 Nonlinearity was
tested through the likelihood ratio test to compare models
with one linear term vs both linear and cubic spline terms.
We presented Kaplan-Meier survival curves for suicide mor-
tality by MWI quartiles.
For our second outcome, mental HRQOL, we used
mixed-effects models to examine MWI and all SF-36 scales
and summary component scores. MWI was assessed contin-
uously and categorically with each of eight SF-36 scales and
two summary measures.
For both sets of analyses, we adjusted for all covari-
ates. Given the strong correlation between current and
future HRQOL, we adjusted for each respective SF-36
scale or summary measure at baseline to minimize the
potential influence of current HRQOL. Despite potential
overadjustment, the regression coefficient provides a pre-
diction and is preferred over change scores.33 Analyses
used Statistical Analysis System software v.9.4 (SAS
Institute, Cary, NC, 2013).
RESULTS
Participant Characteristics
We included 252 002 participants (N = 102 854 NHS,
N = 103 584 NHS II, N = 45 564 HPFS) who completed the
biennial questionnaire in 1992 or 1993 and had complete
data on physician-diagnosed chronic conditions to compute
MWI. Table 1 shows the baseline characteristics stratified by
median MWI. On average, MWI was higher in older women
(NHS) than men and younger women (NHS II).
At baseline, mean SF-36 scales and summary component
measures were close to general population norms (Supplemental
Table S1). On average, younger women had lower MCS and
higher PCS than older women, consistent with US normative
data, whereby mental HRQOL improves with age while physi-
cal HRQOL declines.16
After follow-up through 2000-2001, the mean age was
age 66.0 (7.1) in NHS and 46.5 (4.6) years in NHS II. The
SF-36 physical functioning scale that was used to weight
diseases in MWI was moderately correlated with PCS after
follow-up (Pearson’s r = 0.56 in NHS, r = 0.45 in NHS II).
Physical functioning was only weakly correlated with MCS
at follow-up (Pearson’s r = 0.06 in NHS, r = 0.09 in NHS
II), as expected due to the orthogonal design of SF-36 phys-
ical and mental health constructs. MCS and all mental
HRQOL scales increased while PCS and all physical
HRQOL scales declined (Supplemental Table S1).
Multimorbidity and Risk of Suicide Mortality
There were 341 cases of suicide mortality between
1992-1993 and 2016. The greatest absolute number and
rate of suicide occurred in men (N = 154, 14.1/100 000),
compared with younger women in NHS II (N = 110,
4.62/100 000) and older women in NHS (N = 77, 3.12/100
000). For causes of death, suicide comprised the highest
percentage in younger women in NHS II (3.8% deaths)
compared with men (0.79% deaths) and older women in
NHS (0.22% deaths). The most common suicide method
in women was poisoning by solid or liquid substances; in
men, it was firearms and explosives.
We assessed for nonlinearity using fractional polyno-
mials and restricted cubic splines. Based on restricted cubic
splines (but not fractional polynomials), nonlinearity
occurred at high MWI values, but we observed essentially
linear relationships with mortality through MWI values of
12 to 15 for NHS, 14 to 18 for HPFS, and 20 to 26 for
NHS II (Figure 1). Although extreme MWI values increased
mortality disproportionately, MWI had an essentially linear
relationship with suicide mortality throughout values com-
monly observed in community-dwelling adults.
In unadjusted models, each point increase in MWI was
significantly associated with 9% to 19% higher suicide mor-
tality in the three cohorts (Table 2; Supplemental Table S2).
In fully adjusted models, there was mild attenuation to 5% to
15% higher suicide mortality for each point increase in MWI.
These results were significant for women and men.
The association between multimorbidity and suicide
mortality was stronger for women than men. In fully adjusted
models, suicide mortality risk tripled for younger and older
women in the highest vs lowest quartile MWI (Table 2). After
including regular use of antidepressants and tranquilizers as
morbidities in MWI, the risk of suicide mortality was even
greater. NHS II women with the highest quartile MWI had
more than a 4.5-fold increased risk of suicide mortality vs
those in the lowest quartile (HR = 4.64, 95% CI = 2.68-8.03)
in fully adjusted models (Supplemental Table S2).
In men, suicide mortality risk was nearly double for those
in the highest vs lowest quartile MWI (HR = 1.74, 95%
CI = 1.08-2.81). After including morbidities from antidepres-
sant and tranquilizer use, suicide mortality risk doubled
(HR = 2.01, 95% CI = 1.23-3.28) in fully adjusted models.
In models of MWI that included medication use, there
was suggestion of a dose-response association with greater
MWI and increased suicide mortality. Kaplan-Meier sur-
vival curves for suicide mortality for all cohorts using the
original MWI based on self-reported conditions only are
shown in Figure 2.
For individuals with physical conditions only (models
excluded those with mental health and substance use condi-
tions), increased suicide mortality risk persisted (Supple-
mental Table S3).
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Multimorbidity and Mental HRQOL
Associations between multimorbidity and mental
HRQOL 8 years later are shown (Supplemental Tables
S4 and S5 and Figure 3). Older women in NHS with the
highest quartile MWI had a lower MCS than those with
the lowest quartile MWI (ß = −0.83, 95% CI = −0.99 to
−0.68). After adjustment for baseline MCS and covari-
ates, the association was attenuated to a −0.61 (95%
CI = −0.78 to −0.44) point worse MCS. A similar pat-
tern of attenuation in MCS after adjustment was
Table 1. Multimorbidity Characteristics of Participantsa
NHS NHS II HPFS













No. of participants (%) 49 573 (48.2) 53 358 (51.8) 47 493 (45.9) 56 091 (54.1) 22 813 (50.1) 22 751 (49.9)
Age, y, mean (SD) 56.4 (7.0) 60.2 (6.9) 37.7 (4.6) 39.0 (4.5) 57.1 (8.8) 63.7 (9.5)
White race (%) 46 565 (93.9) 49 812 (93.3) 44 300 (93.3) 52 292 (93.2) 20 633 (90.4) 20 496 (90.1)
Body mass index, kg/m2,
mean (SD)
25.7 (4.7) 27.1 (5.6) 24.2 (4.7) 26.3 (6.1) 25.5 (3.1) 26.1 (3.6)
<18.5 (%) 685 (1.4) 727 (2.2) 1203 (2.5) 1064 (1.9) 66 (0.29) 69 (0.30)
18.5-24.9 (%) 26 226 (52.9) 21 022 (39.4) 31 331 (66.0) 28 727 (51.2) 10 451 (45.8) 9167 (40.3)
25-29.9 (%) 15 506 (31.3) 18 293 (34.3) 9817 (20.7) 13 832 (24.7) 10 454 (44.8) 10 786 (47.4)
30-34.9 (%) 5166 (10.4) 8614 (16.1) 3354 (7.1) 6929 (12.4) 1588 (7.0) 2213 (9.7)
≥35 (%) 1990 (4.0) 4702 (8.8) 1788 (3.8) 5539 (9.9) 254 (1.1) 516 (2.3)
Tobacco abuse
Never (%) 22 390 (45.2) 22 654 (42.5) 32 139 (67.7) 35 010 (62.4) 10 849 (47.6) 8637 (38.0)
Former (%) 19 010 (38.4) 23 023 (43.1) 10 422 (21.9) 13 835 (24.7) 8746 (38.3) 11 007 (48.4)
Current (%) 8173 (16.5) 7681 (14.4) 4932 (10.4) 7246 (12.9) 1652 (7.2) 1601 (7.0)
Geographic region
West (%) 6007 (12.1) 6670 (12.5) 6036 (12.7) 7354 (13.1) 5448 (23.9) 4957 (21.8)
Midwest (%) 8921 (18.0) 10 423 (19.5) 13 152 (27.7) 15 926 (28.4) 6225 (27.3) 6193 (27.2)
Northeast (%) 31 023 (62.6) 32 031 (60.0) 13 835 (29.1) 16 760 (29.9) 6282 (27.5) 6556 (28.8)
South (%) 3622 (7.3) 4234 (7.9) 8276 (17.4) 7936 (14.2) 4831 (21.2) 5033 (22.1)
Married (%) 33 958 (83.0) 37 970 (80.0) 33 517 (70.6) 38 535 (68.7) 17 755 (77.8) 17 961 (79.0)
Lives alone (%) 4115 (8.3) 6162 (11.6) 44 007 (92.7) 4878 (8.7) 1407 (6.2) 1395 (6.1)
Religious service
attendance
NA NA NA NA
Never (%) 8239 (23.9) 9572 (23.8)
<1/wk (%) 7803 (22.6) 9059 (22.5)
≥1/wk (%) 18 443 (53.4) 21 562 (53.6)
Alcohol intake, g/d, mean
(SD)
5.3 (9.5) 4.8 (9.5) 3.1 (6.1) 3.0 (6.1) 9.9 (13.5) 10.5 (15.0)
Medication useb NA NA
Antidepresssant 2597 (5.5) 8918 (15.9) 598 (1.3) 591 (1.3)
Mild tranquilizer (%) 302 (0.6) 1475 (2.6) 890 (1.9) 882 (1.9)
Major tranquilizer (%) 35 (0.1) 146 (0.3) 33 (0.1) 33 (0.1)
Coffee intake, cups/d
0 (%) 9591 (26.8) 12 837 (31.0) 15 399 (32.4) 18 370 (32.7) 5622 (24.6) 6047 (26.6)
<1 (%) 4526 (12.7) 5629 (13.6) 6610 (13.9) 7635 (13.6) 3517 (15.4) 3810 (16.8)
1 (%) 5123 (14.3) 6526 (15.8) 5278 (11.1) 6196 (11.1) 2586 (11.3) 2767 (12.2)
2-3 (%) 11 861 (33.2) 12 021 (29.1) 10 303 (21.7) 11 966 (21.3) 4558 (20.0) 4194 (18.4)






53.2 (6.6) 45.0 (10.3) 55.4 (5.7) 51.0 (8.8)
Mental Component
Summary (MCS)
51.8 (8.2) 51.8 (9.2) 48.6 (8.8) 46.7 (10.1)
Multimorbidity-Weighted
Index, mean (SD)
0.44 (0.59) 5.6 (3.5) 0.005 (0.03) 2.51 (2.4) 0.26 (0.41) 4.24 (3.0)
Disease count, mean
(SD)
0.63 (0.76) 3.2 (1.8) 0.02 (0.14) 1.86 (1.2) 0.59 (0.76) 3.42 (2.0)
aBy MWI median at baseline in 1992 (NHS I, HPFS) or 1993 (NHS II).
bCurrent regular medication use of antidepressants (tricyclic antidepressants, fluoxetine, etc), minor tranquilizers (eg, diazepam, alprazolam, lorazepam, clo-
nazepam, chlordiazepoxide, etc), and major tranquilizers (eg, haloperidol, trifluoperazine, chlorpromazine, fluphenazine, thioridazine, perphenazine, etc).
HPFS = Health Professionals Follow-up Study; MCS = mental component summary; MWI = multimorbidity-weighted index; NA = not available;
NHS = Nurses’ Health Study; NHS II = Nurses’ Health Study II; PCS = physical component summary; SD = standard deviation.
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observed with MWI as a continuous measure (Supple-
mental Table S4).
Among younger women in NHS II, who tended to have
less multimorbidity, the association between MWI on MCS
was greater than for women in NHS. In unadjusted models,
women with the highest quartile MWI had a −1.25 (95%
CI = −1.44 to −1.06) worse MCS compared with those in
the lowest quartile MWI. Each point increase in MWI was
associated with a 0.26-point decrease in MCS (Supplemental
Table S4 and Figure 3). In models adjusting for covariates
except baseline MCS, the effect of each point increase in
MCS was greater. Further adjustment for baseline MCS
attenuated the association modestly. For comparison, the
association of 1-point increase in MWI with MCS was 5 to
10 times greater than that of a 1-year increase in age.
Among individual mental HRQOL scales, MWI was asso-
ciated with the greatest decrement in social functioning, fol-
lowed by general health, vitality, role-emotional, and mental
health. However, we observed statistically significant adverse
associations of MWI with lower mental HRQOL for all scales.
Figure 1. Restricted cubic splines for suicide mortality by multimorbidity-weighted index (MWI) in (A) the Nurses’ Health Study
(NHS), (B), the Nurses’ Health Study II, and (C) the Health Professionals Follow-up Study, from 1992 or 1993 to 2016. Curves
represent the hazard ratio (HR) for suicide mortality (solid line) with corresponding 95% confidence intervals (gray surrounding
lines and cloud). At lower values of the MWI, there were essentially linear relationships with suicide mortality; at higher values of
the MWI, there were disproportionately higher HRs for suicide mortality.
Table 2. Hazard Ratios for Suicide Mortality by Multimorbidity-Weighted Indexa
NHS (N = 102 854) NHS II (N = 103 584) HPFS (N = 45 564) Pooled cohorts (N = 252 003)
No. suicide deaths 77 110 154 341
Model HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
MWI, continuous
Unadjusted 1.09 (1.04-1.15) <.001 1.17 (1.11-1.23) <.001 1.10 (1.05-1.16) <.001 1.12 (1.09-1.15) <.001
Model 1b 1.10 (1.04-1.15) <.001 1.14 (1.08-1.21) <.001 1.06 (1.00-1.12) .036 1.10 (1.07-1.13) <.001
Model 2c 1.09 (1.03-1.14) .002 1.13 (1.06-1.19) <.001 1.05 (1.00-1.11) .060 1.09 (1.06-1.12) <.001
MWI, unadjusted
Q4 vs Q1 2.98 (1.54-5.80) .001 3.95 (2.41-6.48) <.001 2.36 (1.51-3.69) <.001 3.06 (2.76-3.35) <.001
Q3 vs Q1 1.14 (0.53-2.47) .739 1.87 (1.09-3.20) .023 2.03 (1.32-3.14) .001 1.84 (1.53-2.14) <.001
Q2 vs Q1 1.71 (0.83-3.53) .145 1.82 (1.03-3.20) .038 1.07 (0.63-1.81) .811 1.48 (1.14-1.82) <.001
Q1c (reference) 1.0 1.0 1.0 1.0
MWI, model 1b
Q4 vs Q1 3.20 (1.59-6.45) .001 3.19 (1.91-5.33) <.001 1.78 (1.11-2.85) .016 2.72 (2.38-3.05) <.001
Q3 vs Q1 1.24 (0.57-2.72) .588 1.65 (0.95-2.84) .073 1.77 (1.14-2.76) .011 1.65 (1.33-1.96) <.001
Q2 vs Q1 1.82 (0.88-3.76) .108 1.71 (0.97-3.02) .062 1.01 (0.59-1.71) .984 1.40 (1.07-1.72) <.001
Q1d (reference) 1.0 1.0 1.0 1.0
MWI, model 2c
Q4 vs Q1 3.01 (1.48-6.11) .002 3.04 (1.82-5.09) <.001 1.74 (1.08-2.81) .022 2.47 (2.16-2.79) <.001
Q3 vs Q1 1.23 (0.56-2.69) .612 1.60 (0.93-2.77) .090 1.76 (1.13-2.74) .012 1.62 (1.30-1.94) <.001
Q2 vs Q1 1.78 (0.86-3.69) .121 1.70 (0.97-3.00) .065 1.01 (0.59-1.71) .985 1.43 (1.09-1.77) <.001
Q1d (reference) 1.0 1.0 1.0 1.0
aContinuous and quartiles between 1992 (NHS, HPFS) or 1993 (NHS II) to 2016.
bAdjusted for age, race, body mass index, smoking status, geographic region.
cFurther adjusted for alcohol consumption (0 g/d or tertile of intake) and coffee intake, marital status, living alone, and additionally in the NHS, religious ser-
vice attendance.
dFor NHS II, the referent category Q1 is MWI values of 0, due to the left skew in this cohort with many participants with MWI values of 0 (ie, ties to 0).
CI = confidence interval; HPFS = Health Professionals Follow-up Study; HR = hazard ratio; MWI = multimorbidity-weighted index; NA = not available;
NHS = Nurses’ Health Study; NHS II = Nurses’ Health Study II; Q = quartile.
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For comparison with mental HRQOL, we show associ-
ations between multimorbidity and physical HRQOL (Sup-
plemental Table S5 and Figure 3). In general, and as
expected from its weighting to current physical functioning,
MWI was associated with decrements in future physical
HRQOL larger than for mental HRQOL, with consistent
associations across subscales. As with mental HRQOL,
each point increase in MWI was associated with worse
physical HRQOL on average in younger women (NHS II)
than older women (NHS), although younger women were
less likely to have multimorbidity.
DISCUSSION
In this large prospective study of 252 002 young through
older community-dwelling adults, multimorbidity was
strongly associated with increased suicide mortality and
decreased mental HRQOL. Those with the highest quartile
of multimorbidity had a two - fourfold higher risk of sui-
cide mortality compared with those in the lowest quartile.
Collectively, these findings suggest multimorbidity has an
important role in the progression of HRQOL across all
mental and physical domains and with risk of suicide mor-
tality, spanning the full continuum of multimorbidity.
Our finding that multimorbidity is associated with
increased suicide is consistent with and extends previous
studies. Prior studies reported physical health conditions,
even after adjustment for mental health and substance abuse
diagnoses, were associated with increased suicide behavior
and mortality.7,9 Webb et al similarly reported a dose-
response association with more physical conditions and risk
of self-harm, independent of depression in women only.34
Another study reported multimorbidity from mental and
physical health conditions was associated with increased sui-
cidal ideation, but not beyond that of having a common
mental disorder only.35 Although mental health conditions
Figure 2. Kaplan-Meier survival curves for suicide mortality by multimorbidity-weighted index (MWI) quartiles in (A), the Nurses’
Health Study (NHS), (B), the Nurses’ Health Study II, and (C), the Health Professionals Follow-up Study, from 1992 or 1993 to
2016. There was suggestion of a dose-response association between increasing quartiles of the MWI and worse survival over
24 years of follow-up for suicide mortality. All nonsuicide causes of death and nondeaths were censored.
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predicted suicide ideation, it was less helpful in determining
who would make an attempt. In contrast to studies of suicide
behavior, we examined completed suicide. We also had a
large sample size spanning young through older adults with
a long duration of follow-up, comprehensive assessment of
multimorbidity accounting for disease severity, and broad
control for confounding over several domains. Further, by
examining health professionals, we expect less misclassifica-
tion of self-reported chronic conditions and thus findings
that more closely mimic relationships expected using diseases
identified in medical records.
Previous studies also reported on the association
between multimorbidity and decreased HRQOL using vari-
ous measures but were largely cross-sectional designs at
midlife36,37 and in older adults38 without adjustment for
current HRQOL. Our prospective study demonstrated that
the burden of multimorbidity on HRQOL persisted 8 years
later. We adjusted for current HRQOL to avoid ambiguities
of reverse causality and to estimate the effect of incident
multimorbidity. Although MWI was developed using con-
current physical functioning, MWI was also associated with
mental HRQOL, although that SF-36 mental and PCS mea-
sures are orthogonal (uncorrelated) by design. Indeed, while
MWI predicted PCS years later with nearly the same pre-
dicted weighting as at baseline, MWI was associated with a
decline in MCS roughly one quarter that of PCS, confirming
multimorbidity has a clear, quantifiable link to future men-
tal health even when indexed to physical health.
Although younger women are less likely to have multi-
morbidity than older women, those who did reported poor
HRQOL worse than that of older women. There are several
possible explanations for this finding. First, some conditions
affecting younger women may be more virulent, particu-
larly early in the disease course. For example, connective
tissue disease, inflammatory bowel disease, and breast
cancer had a greater impact on physical functioning in
younger NHS II women than older NHS women.14 Second,
younger adults may have been more recently diagnosed
and/or had less time for treatment and adaptation than
older adults. For example, stroke is often worse earlier in
the disease course. Finally, HRQOL is a self-reported per-
ception of the impact of disease on one’s state of health. A
“response shift” may occur whereby there is a change in the
participant’s internal standards or values, resulting in a reca-
libration of the SF-36 or reconceptualization of HRQOL
over time as other aspects in life change.39 Social compari-
sons may also contribute to response shift. For example,
older adults may downplay their limitations if they compare
themselves with peers with worse disability. In contrast,
younger adults may compare themselves with healthy peers.
Our study has potential limitations. First, MWI
includes mostly physical conditions and is thus an underes-
timate of mental conditions. The original MWI included
self-reported conditions, but for robustness, we added to
MWI morbidities from antidepressant and tranquilizer use.
Opiate use was unavailable but much less commonly used
at baseline.40 Nevertheless, MWI remained associated with
mental HRQOL, consistent with studies reporting physical
conditions, irrespective of comorbid mental conditions, are
associated with increased suicide behavior and mortality.7,9
Overall, these features highlight the role of physical multi-
morbidity in predicting future mental health but suggest
that indices incorporating mental health conditions would
have even stronger effects.
Another limitation was participants were predominantly
white health professionals, although geographically diverse
with disease prevalences and lifestyles reflecting those of gen-
eral US and other industrialized populations.41–44 Health
professionals may have easier access to medications com-
pared with the general population,45,46 although we were
Figure 3. Short Form-36 scales and summary component measures per point increase in the multimorbidity-weighted index (MWI)
after 8-year follow-up in the Nurses’ Health Study (left-hand solid-colored columns, 1992-2000) and Nurses’ Health Study II
(right-hand diagonal hashed columns, 1993-2001) in adjusted models. A, Physical health-related quality of life scales and the physi-
cal component summary measure. B, Mental health-related quality of life scales and the mental component summary measure. His-
tograms represent the regression coefficients with corresponding 95% confidence intervals as the error bars. Each point increase in
the MWI was associated with significantly worse health-related quality of life across all mental and physical scales and summary
component measures. [Color figure can be viewed at wileyonlinelibrary.com]
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unable to compare suicide methods by occupation. Further
studies on suicide mortality are needed in diverse popula-
tions. Finally, long-term HRQOL results are restricted to
women. One scale, physical functioning, was available in
men and persisted over follow-up.21
In this prospective study, an easily measured multimor-
bidity index capturing a comprehensive inventory of condi-
tions was strongly associated with increased suicide
mortality and decreased mental HRQOL in young through
older community-dwelling adults. These results support a
role for MWI in capturing mental health, despite being
weighted specifically to physical functioning. MWI may
serve as a useful tool and Web-based or electronic medical
record portal application for healthcare providers consider-
ing broader, long-term consequences of multimorbidity.
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